Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

BNT-113

Generic Name: BNT-113

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Phase 2

Recruiting

Posted: 2020/09/01

Sponsor:BioNTech SE

ID:NCT04534205

HARE-40: HPV Anti-CD40 RNA vaccinE

Phase 1

Completed

Posted: 2018/02/01

Sponsor:University of Southa...

ID:NCT03418480

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

UK Partners with BioNTech on Clinical Trials of mRNA Cancer Therapies

5 months ago

The UK has partnered with German biotech BioNTech to provide up to 10,000 patients with access to personalised cancer therapies through clinical trials, leveraging mRNA technology. This collaboration, extending to 2030, also includes the potential supply of commercial therapies and covers infectious disease targets. BioNTech will establish an R&D centre in Cambridge and an office in London, with the possibility of manufacturing investments in the UK.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy